Therapeutic potential of the nitrite-generated NO pathway in vascular dysfunction

Frontiers in Immunology

Volumn 4, Issue JUL, 2013, Pages

  Madigan, Michael ^a   Zuckerbraun, Brian ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Atherosclerosis; Neointimal hyperplasia; Nitrate; Nitric oxide; Nitrite; Peripheral vascular disease; Pulmonary hypertension; Review

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ALDEHYDE OXIDASE; ARGINASE; ARGININE; BRADYKININ; CITRULLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEMOGLOBIN; HISTAMINE; MYOGLOBIN; NITRATE; NITRIC OXIDE; NITRITE; ORNITHINE; PROSTACYCLIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SULFITE OXIDASE; SUPEROXIDE; UREA; XANTHINE OXIDASE;

ACIDEMIA; ANGIOGENESIS; ATHEROSCLEROSIS; BIOAVAILABILITY; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CELL MIGRATION; CELL PROLIFERATION; HUMAN; HYPERPLASIA; HYPOXIA; LEUKOCYTE ADHERENCE; METABOLISM; NEOINTIMA; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PULMONARY HYPERTENSION; REVIEW; SMOOTH MUSCLE FIBER; THROMBOCYTE ADHESION; VASCULAR DISEASE; VASODILATATION;

EID: 84883725551     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00174     Document Type: Review

References (113)

1. Bryan NS, Bian K, Murad F. Discovery of the nitric oxide signaling pathway and targets for drug development. Front Biosci (2009) 14:1-18.
2. Alderton W.K Cooper CE, Knowles RG. Nitric oxide synthases: structure, function, and inhibition. Biochem J (2001) 357(Pt 3):593-615. doi:10.1042/0264-6021:3570593
3. Li H, Meininger CJ, Hawker JR Jr, Haynes TE, Kepka-Lenhart D, Mistry SK, et al. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline synthesis in endothelial cells. Am J Physiol Endocrinol Metab (2001) 280:E75-82.
4. Allen JD, Giordano T, Kevil CG. Nitrite and nitric oxide metabolism in peripheral artery disease. Nitric Oxide (2012) 26:217-22. doi:10.1016/j.niox.2012.03.003
5. Alef MJ, Vallabhaneni R, Carchman E, Morris SM Jr, Shiva S, Wang Y, et al. Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley rats. J Clin Invest (2011) 121(4):1646-56. doi:10.1172/JCI44079
6. Lundberg JO, Gladwin MT, Ahluwalia A, Benjamin N, Bryan NS, Butler A, et al. Nitrate and nitrite in biology, nutrition and therapeutics. Nat Chem Biol (2009) 5:865-9. doi:10.1038/nchembio.260
7. Zuckerbraun BS, George P, Glawin MT. Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signaling. Cardiovasc Res (2011) 89(3):542-52. doi:10.1093/cvr/cvq370
8. Pernow J, Jung C. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?. Cardiovasc Res (2013) 98(3):334-43. doi:10.1093/cvr/cvt036
9. Jung C, Gonon AT, Sjöquist PO, Lundberg JO, Pernow J. Arginase inhibition mediates cardioprotection during ischemia-reperfusion. Cardiovasc Res (2010) 85:147-54. doi:10.1093/cvr/cvp303
10. Zhang C, Hein TW, Wang W, Miller MW, Fossum TW, McDonald MM, et al. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension (2004) 44:935-43. doi:10.1161/01.HYP.0000146907.82869.f2
11. Grönros J, Jung C, Lundberg JO, Cerrato R, Ostenson CG, Pernow J. Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats. Am J Physiol Heart Circ Physiol (2011) 300:H1174-81. doi:10.1152/ajpheart.00560.2010
12. Alef MJ, Tzeng E, Zuckerbraun BS. Nitric oxide and nitrite-based therapeutic opportunities in intimal hyperplasia. Nitric Oxide (2012) 26:285-94. doi:10.1016/j.niox.2012.03.014
13. Peyton KJ, Ensenat D, Azam MA, Keswani AN, Kannan S, Liu XM, et al. Arginase promotes neointima formation in rat injured carotid arteries. Arterioscler Thromb Vasc Biol (2009) 29:488-94. doi:10.1161/ATVBAHA.108.183392
14. Kleinbongard P, Dejam A, Lauer T, Rassaf T, Schindler A, Picker O, et al. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med (2003) 35(7):790-6. doi:10.1016/S0891-5849(03)00406-4
15. Rhodes P, Leone AM, Francis PL, Struthers AD, Moncada S, Rhodes PM [corrected to Rhodes P]. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun (1995) 209(2):590-6. doi:10.1006/bbrc.1995.1541
16. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature (1995) 377(6546):239-42. doi:10.1038/377239a0
17. Golino P, Cappelli-Bigazzi M, Ambrosio G, Ragni M, Russolillo E, Condorelli M, et al. Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation. Circ Res (1992) 71(6):1447-56. doi:10.1161/01.RES.71.6.1447
18. Hansson GK, Geng YJ, Holm J, Hårdhammar P, Wennmalm A, Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med (1994) 180(2):733-8. doi:10.1084/jem.180.2.733
19. Keitadisorn R, Juni RP, Moens AL. Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities. Am J Physiol Endocrinol Metab (2012) 302:E481-95. doi:10.1152/ajpendo.00540.2011
20. Katusic ZS. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?. Am J Physiol Heart Circ Physiol (2001) 281(3):H981-6.
21. Khoo JP, Zhao L, Alp NJ, Bendall JK, Nicoli T, Rockett K, et al. Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension. Circulation (2005) 111:2126-33. doi:10.1161/01.CIR.0000162470.26840.89
22. Stuehr D, Pou S, Rosen GM. Oxygen reduction by nitric oxide synthases. J Biol Chem (2001) 276:14533-6. doi:10.1074/jbc. R100011200
23. Jacobson A, Yan C, Gao Q, Rincon-Skinner T, Rivera A, Edwards J, et al. Aging enhances pressure-induced arterial superoxide formation. Am J Physiol Heart Circ Physiol (2007) 293:H1344-50. doi:10.1152/ajpheart.00413.2007
24. Tabima DM, Frizzell S, Gladwin MT. Reactive oxygen and nitrogen species in pulmonary hypertension. Free Radic Biol Med (2012) 52(9):1970-86. doi:10.1016/j.freeradbiomed.2012.02.041
25. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension. Hypertension (2004) 44:248-52. doi:10.1161/01.HYP.0000138070.47616.9d
26. Baliga RS, Milsom AB, Ghosh SM, Trinder SL, Macallister RJ, Ahluwalia A, et al. Dietary nitrate ameliorates pulmonary hypertension: cytoprotective role for endothelial nitric oxide synthase and xanthine oxidoreductase. Circulation (2012) 125(23):2922-32. doi:10.1161/CIRCULATIONAHA.112.100586
27. Dejam A, Hunter CJ, Schechter AN, Gladwin M. Emerging role of nitrite in human biology. Blood Cells Mol Dis (2004) 32(3):423-9. doi:10.1016/j.bcmd.2004.02.002
28. Gladwin MT, Raat NJ, Shiva S, Dezfulian C, Hogg N, Kim-Shapiro DB, et al. Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection, and vasodilation. Am J Physiol Heart Circ Physiol (2006) 291(5):H2026-35. doi:10.1152/ajpheart.00407.2006
29. Murata I, Nozaki R, Ooi K, Ohtake K, Kimura S, Ueda H, et al. Nitrite reduces ischemia/reperfusion-induced muscle damage and improves survival rates in rat crush injury model. J Trauma Acute Care Surg (2012) 72(6):1548-54. doi:10.1097/TA.0b013e31824a76b5
30. Huang Z, Shiva S, Kim-Shapiro DB, Patel RP, Ringwood LA, Irby CE, et al. Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest (2005) 115(8):2099-107. doi:10.1172/JCI24650
31. Li H, Cui H, Kundu TK, Alzawahra W, Zweier JL. Nitric oxide production from nitrite occurs primarily in tissues not in the blood. J Biol Chem (2008) 283:17855-63. doi:10.1074/jbc. M801785200
32. Godber BL, Doel JJ, Sapkota GP, Blake DR, Stevens CR, Eisenthal R, et al. Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. J Biol Chem (2000) 275(11):7757-63. doi:10.1074/jbc.275.11.7757
33. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med (2003) 9(12):1498-505. doi:10.1038/nm954
34. Nagabubu E, Ramasamy S, Abernethy DR, Rifkind JM. Active nitric oxide produced in the red cell under hypoxic conditions by deoxyhemoglobin-mediated nitrite reduction. J Biol Chem (2003) 278(47):46349-56. doi:10.1074/jbc. M307572200
35. Shiva S, Huang Z, Grubina R, Sun J, Ringwood LA, MacArthur PH et al. Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res (2007) 100(5):654-61.
36. Rassaf T, Flögel U, Drexhage C, Hendgen-Cotta U, Kelm M, Schrader J. Nitrite reductase function of deoxymyoglobin: oxygen sensor and regulator of cardiac energetics and function. Circ Res (2007) 100(12):1749-54. doi:10.1161/CIRCRESAHA.107.152488
37. Zweier JL, Samouilov A, Kuppusamy P. Non-enzymatic nitric oxide synthesis in biological systems. Biochem Biophys Acta (1999) 1411(2-3):250-62. doi:10.1016/S0005-2728(99)00018-3
38. Maia LB, Moura JJG. Nitrite reduction by xanthine oxidase family enzymes: a new class of nitrite reductases. J Biol Inorg Chem (2011) 16:443-60. doi:10.1007/s00775-010-0741-z
39. Tripatara P, Patel NS, Webb A, Rathod K, Lecomte FM, Mazzon E, et al. Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase. J Am Soc Nephrol (2007) 18:570-80. doi:10.1681/ASN.2006050450
40. Lundberg JO, Feelisch M, Björne H, Jansson EA, Weitzberg E. Cardioprotective effects of vegetables: is nitrite the answer?. Nitric Oxide (2006) 15(4):359-62. doi:10.1016/j.niox.2006.01.013
41. Lidder S, Webb AJ. Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway. Br J Clin Pharmacol (2012) 75(3):677-96.
42. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet (1994) 343(8911):1454-9. doi:10.1016/S0140-6736(94)92580-1
43. Larsen FJ, Ekblom B, Sahlin K, et al. Effects of dietary nitrate on blood pressure in healthy volunteers. N Engl J Med (2006) 355(26):2792-3. doi:10.1056/NEJMc062800
44. Duncan C, Dougall H, Johnston P, Green S, Brogan R, Leifert C, et al. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrite. Nat Med (1995) 1(6):546-51. doi:10.1038/nm0695-546
45. Benjamin N, O'Driscoll F, Dougall H, Duncan C, Smith L, Golden M, et al. Stomach NO synthesis. Nature (1994) 368:502. doi:10.1038/368502a0
46. Björne HH, Petersson J, Phillipson M, Weitzberg E, Holm L, Lundberg JO. Nitrite in saliva increases gastric mucosal blood flow and mucus thickness. J Clin Invest (2004) 113(1):106-14. doi:10.1172/JCI19019E1
47. McKnight GM, Smith LM, Drummond RS, Duncan CW, Golden M, Benjamin N. Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans. Gut (1997) 40(2):211-4.
48. Miyoshi M, Kasahara E, Park AM, Hiramoto K, Minamiyama Y, Takemura S, et al. Dietary nitrate inhibits stress-induced gastric mucosal injury in the rat. Free Radic Res (2003) 37(1):85-90. doi:10.1080/1071576021000086632
49. Milkowski A, Garg HK, Coughlin JR, Bryan NS. Nutritional epidemiology in the context of nitric oxide biology: a risk-benefit evaluation for dietary nitrite and nitrate. Nitric Oxide (2010) 22:110-9. doi:10.1016/j.niox.2009.08.004
50. Hecht SS. Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis. Proc Soc Exp Biol Med (1997) 216(2):181-91.
51. National Toxicology Program. Toxicology and carcinogenesis of sodium nitrite (CAS NO. 7632-00-0) in F344/N rats and B6C3F1 mice (drinking water studies). Natl Toxicol Program Tech Rep Ser (2001) 495:7-273.
52. International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks to humans: ingested nitrates and nitrites. IARC (2006). Available at: http://monographs.iarc.fr/ENG/Monographs/vol94/mono94-6.pdf
53. Sobko T, Marcus C, Govoni M, Kamiya S. Dietary nitrate in Japanese traditional foods lowers diastolic blood pressure in healthy volunteers. Nitric Oxide (2010) 22(2):136-40. doi:10.1016/j.niox.2009.10.007
54. Hunter CJ, Dejam A, Blood AB, Shields H, Kim-Shapiro DB, Machado RF, et al. Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator. Nat Med (2004) 10:1122-7. doi:10.1038/nm1109
55. Ahanchi SS, Tsihlis ND, Kibbe MR. The role of nitric oxide in the pathophysiology of intimal hyperplasia. J Vasc Surg (2007) 45(Suppl A):A64-73. doi:10.1016/j.jvs.2007.02.027
56. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet (1987) 2(8567):1057-8. doi:10.1016/S0140-6736(87)91481-4
57. Yan ZQ, Yokota T, Zhang W, Hansson GK. Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res (1996) 79:38-44. doi:10.1161/01.RES.79.1.38
58. de Graaf JC, Banga JD, Moncada S, Palmer RM, de Groot PG, Sixma JJ. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation (1992) 85(6):2284-90. doi:10.1161/01.CIR.85.6.2284
59. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A (1990) 87(13):5193-7. doi:10.1073/pnas.87.13.5193
60. Park JW, Piknova B, Huang PL, Noguchi CT, Schechter AN. Effect of blood nitrite and nitrate levels on murine platelet function. PLoS ONE (2013) 8(2):e55699. doi:10.1371/journal.pone.0055699
61. Hickey MJ, Sharkey KA, Sihota EG, Reinhardt PH, Macmicking JD, Nathan C, et al. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte- endothelium interactions in endotoxemia. FASEB J (1997) 11:955-64.
62. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A (1991) 88:4651-5. doi:10.1073/pnas.88.11.4651
63. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 327:524-6. doi:10.1038/327524a0
64. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J (1995) 9:1319-30.
65. Sarkar R, Gordon D, Stanley JC, Webb RC. Cell cycle effects of nitric oxide on vascular smooth muscle cells. Am J Physiol (1997) 272:H1810-8.
66. Ishida A, Sasaguri T, Kosaka C, Nojima H, Ogata J. Induction of the cyclindependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells. J Biol Chem (1997) 272:10050-7. doi:10.1074/jbc.272.15.10050
67. Kibbe MR, Li J, Nie S, et al. Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate. J Vasc Surg (2000) 31:1214-28. doi:10.1067/mva.2000.105006
68. Tanner FC, Meier P, Greutert H, Champion C, Nabel EG, Lüscher TF. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation (2000) 101:1982-9. doi:10.1161/01.CIR.101.16.1982
69. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest (1989) 85(5):1774-7. doi:10.1172/JCI114081
70. World Health Organization. World health statistics 2012. WHO Library Cataloguing-in-Publications Data. (2012). Accessed from www.who.int/gho/publications/world_health_statistics/2012/en/
71. Fazio S, Linton MF. The inflamed plaque: cytokine production and cellular cholesterol balance in the vessel wall. Am J Cardiol (2001) 88(2A):12E-5. doi:10.1016/S0002-9149(01)01717-9
72. Singh RB, Mengi SA, Xu YJ, Arneja AS, Dhalla NS. Pathogenesis of atherosclerosis: a multifactorial process. Exp Clin Cardiol (2002) 7(1):40-53.
73. Ryoo S, Berkowitz DE, Lim HK. Endothelial arginase II and atherosclerosis. Korean J Anesthesiol (2011) 61(1):3-11. doi:10.4097/kjae.2011.61.1.3
74. Kauser K, da Cunha V, Fitch R, Mallari C, Rubanyi GM. Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Physiol Heart Circ Physiol (2000) 278:H1679-85.
75. Girerd XJ, Hirsch AT, Cooke JP, Dzau VJ, Creager MA. L-Arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res (1990) 67:1301-8. doi:10.1161/01.RES.67.6.1301
76. Böger RH, Bode-Böger SM, Brandes RP, Phivthong-ngam L, Böhme M, Nafe R, et al. Dietary L-arginine reduces the progression of atherosclerosis in cholesterol -fed rabbits: comparison with lovastatin. Circulation (1997) 96:1282-90. doi:10.1161/01.CIR.96.4.1282
77. Dhawan V, Handu SS, Nain CK, Ganguly NK. Chronic L-arginine supplementation improves endothelial cell vasoactive functions in hypercholesterolemic and atherosclerotic monkeys. Mol Cell Biochem (2005) 269(1-2):1-11. doi:10.1007/s11010-005-1810-4
78. Raman KG, Gandley RE, Rohland J, Zenati MS, Tzeng E. Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide. J Vasc Surg (2011) 53:754-63. doi:10.1016/j.jvs.2010.09.038
79. Stokes KY, Dugas TR, Tang Y, Garg H, Guidry E, Bryan NS. Dietary nitrite prevents hypercholesterolemic microvascular inflammation and reverses endothelial dysfunction. Am J Physiol Heart Circ Physiol (2009) 296:H1281-8. doi:10.1152/ajpheart.01291.2008
80. Kawashima S, Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Aterioscler Thromb Vasc Biol (2004) 24(6):998-1005. doi:10.1161/01.ATV.0000125114.88079.96
81. Ohara Y, Peterson TE, Sayegh HS, Subramanian RR, Wilcox JN, Harrison DG. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation (1995) 92(4):898-903. doi:10.1161/01.CIR.92.4.898
82. Cathcart M. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages. Arterioscler Thromb Vasc Biol (2004) 24:23-8. doi:10.1161/01.ATV.0000097769.47306.12
83. Dimmeler S, Haendeler J, Galle J, Zeiher AM. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. Circulation (1997) 95:1760-3. doi:10.1161/01.CIR.95.7.1760
84. Galle J, Bengen J, Schollmeyer P, Warner C. Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Role of oxygenderived radicals. Circulation (1995) 92:1582-9.
85. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature (1990) 344:160-2. doi:10.1038/344160a0
86. Ma FX, Zhou B, Chen Z, Ren Q, Lu SH, Sawamura T, et al. Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res (2006) 47(6):1227-37. doi:10.1194/jlr. M500507-JLR200
87. Lloyd PG, Yang HT, Terjung RL. Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide. Am J Physiol Heart Circ Physiol (2001) 281:H2528-38.
88. Pattillo CB, Fang K, Terracciano J, Kevil CG. Reperfusion of chronic tissue ischemia: nitrite and dipyridamole regulation of innate immune response. Ann N Y Acad Sci (2010) 1207:83-8. doi:10.1111/j.1749-6632.2010.05737.x
89. Witzenbichler B, Asahara T, Murohara T, Silver M, Spyridopoulos I, Magner M, et al. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol (1998) 153(2):381-91. doi:10.1016/S0002-9440(10)65582-4
90. van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res (2001) 49:543-53. doi:10.1016/S0008-6363(00)00206-6
91. Yu J, deMuinck ED, Zhuang Z, Drinane M, Kauser K, Rubanyi GM, et al. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci U S A (2005) 102(31):10999-1004. doi:10.1073/pnas.0501444102
92. Kumar D, Branch BG, Pattillo CB, Hood J, Thoma S, Simpson S, et al. Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis. Proc Natl Acad Sci U S A (2008) 105(21):7540-5. doi:10.1073/pnas.0711480105
93. Isenberg JS, Shiva S, Gladwin MT. Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation. Nitric Oxide (2009) 21(1):52-62. doi:10.1016/j.niox.2009.05.005
94. Bir SC, Pattillo CB, Pardue S, Kolluru GK, Docherty J, Goyette D, et al. Nitrite anion stimulated ischemic arteriogenesis involving NO metabolism. Am J Physiol Heart Circ Physiol (2012) 303:H178-88. doi:10.1152/ajpheart.01086.2010
95. Hendgen-Cotta UB, Luedike P, Totzeck M, Kropp M, Schicho A, Stock P, et al. Dietary nitrate supplementation improves revascularization in chronic ischemia. Circulation (2012) 126:1983-92. doi:10.1161/CIRCULATIONAHA.112.112912
96. Petersson J, Carlström M, Schreiber O, Phillipson M, Christoffersson G, Jägare A, et al. Gastroprotective and blood pressure lowering effects of dietary nitrate are abolished by antiseptic mouthwash. Free Radic Biol Med (2009) 46(8):1068-75. doi:10.1016/j.freeradbiomed.2009.01.011
97. Kapil V, Haydar SM, Pearl V, Lundberg JO, Weitzberg E, Ahluwalia A. Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radic Biol Med (2013) 55:93-100. doi:10.1016/j.freeradbiomed.2012.11.013
98. Guo JP, Panday MM, Consigny PM, Lefer AM. Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. Am J Physiol (1995) 269:H1122-31.
99. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, et al. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium. J Biol Chem (1998) 273(7):4220-6. doi:10.1074/jbc.273.7.4220
100. Wei LH, Wu G, Morris SM, Ignarro LJ. Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation. Proc Natl Acad Sci U S A (2001) 98(16):9260-4. doi:10.1073/pnas.161294898
101. Sparacino-Watkins CE, Lai YC, Gladwin MT. Nitrate-nitrite-nitric oxide pathway in pulmonary arterial hypertension therapeutics. Circulation (2012) 125 (23):2824-6. doi:10.1161/CIRCULATIONAHA.112.107821
102. Frostell C, Fratacci MD. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation (1991) 83:2038-47. doi:10.1161/01.CIR.83.6.2038
103. Zuckerbraun BS, Shiva S, Ifedigbo E, Mathier MA, Mollen KP, Rao J et al. Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase-dependent nitric oxide generation. Circulation (2010) 121(1):98-109. doi:10.1161/CIRCULATIONAHA.109.891077
104. Gladwin MT, Schechter AN, Kim-Shapiro DB, Patel RP, Hogg N, Shiva S, et al. The emerging biology of the nitrite anion. Nat Chem Biol (2005) 1(6):308-14. doi:10.1038/nchembio1105-308
105. Totzeck M, Hendgen-Cotta UB, Luedike P, Berenbrink M, Klare JP, SteinhoffHJ, et al. Nitrite regulates hypoxic vasodilation via myoglobin-dependent nitric oxide generation. Circulation (2012) 126(3):325-34. doi:10.1161/CIRCULATIONAHA.111.087155
106. Bloch KD, Ichinose F, Roberts JD Jr, Zapol WM. Inhaled NO as a therapeutic agent. Cardiovasc Res (2007) 75(2):339-48. doi:10.1016/j.cardiores.2007.04.014
107. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med (1995) 333 (4):214-21. doi:10.1056/NEJM199507273330403
108. Tuder RM, Cool CD, Geraci MW, Wang J, Abman SH, Wright L, et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med (1999) 159(6):1925-32. doi:10.1164/ajrccm.159.6.9804054
109. Xue C, Johns RA. Endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med (1995) 333(24):1642-4. doi:10.1056/NEJM199512143332416
110. Hampl V, Bíbová J, Banasová A, Uhlík J, Miková D, Hnilicková O, et al. Pulmonary vascular iNOS induction participates in the onset of chronic hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2006) 290(1):L11-20. doi:10.1152/ajplung.00023.2005
111. Xu W, Kaneko FT, Zheng S, Comhair SA, Janocha AJ, Goggans T, et al. Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB (2004) 18(14):1746-8.
112. Hellsten Y, Nyberg M, Jensen LG, Mortensen SP. Vasodilator interactions in skeletal muscle blood flow regulation. J Physiol (2012) 590:6297-305. doi:10.1113/jphysiol.2012.240762
113. Li H, Samouilov A, Liu X, Zweier JL. Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction. J Biol Chem (2001) 276:24482-9. doi:10.1074/jbc. M011648200